Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1633]
News [6491]
Articles [98]
Editorials [4]
Conferences [184]
elearning [21]
High BMI beneficial in kidney cancer
Dr Laurence Albiges - Dana-Farber Cancer Institute, Boston, USA
High BMI beneficial in kidney cancer ( Dr Laurence Albiges - Dana-Farber Cancer Institute, Boston, USA )
27 Feb 2015
Optimizing survival in advanced prostate cancer: Welcome and introduction
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Welcome and introduction ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Epigenome deregulation in cancer
Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon...
Epigenome deregulation in cancer ( Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France )
6 Jan 2015
Cancer control through vaccination requires global collaboration
Dr Andreas Ullrich - Medical Officer for Cancer Control, World Health...
Cancer control through vaccination requires global collaboration ( Dr Andreas Ullrich - Medical Officer for Cancer Control, World Health Organization )
18 Dec 2014
Cancer and the immune system: exploring the landscape of cancer immunology
Dr Jonathan Cebon - Ludwig Institute for Cancer Research, Melbourne, Australia
Cancer and the immune system: exploring the landscape of cancer immunology ( Dr Jonathan Cebon - Ludwig Institute for Cancer Research, Melbourne, Australia )
17 Dec 2014
Inspiring movement towards a global vision of cancer control
Prof Mary Gospodarowicz - Princess Margaret Cancer Centre, Toronto, Canada
Inspiring movement towards a global vision of cancer control ( Prof Mary Gospodarowicz - Princess Margaret Cancer Centre, Toronto, Canada )
17 Dec 2014
Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype
Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014
CLL at ASH 2014: Expert discussion
Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014
IBIS-I trial: tamoxifen lowered breast cancer rates among high-risk women
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
IBIS-I trial: tamoxifen lowered breast cancer rates among high-risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
11 Dec 2014
Checkpoint inhibitors show safety and efficacy in Hodgkin lymphoma
Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
Checkpoint inhibitors show safety and efficacy in Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Dec 2014
Predicting the relapse of acute myeloid leukaemia with genetic screening
Dr Elaine Mardis - University of Washington, Washington, USA
Predicting the relapse of acute myeloid leukaemia with genetic screening ( Dr Elaine Mardis - University of Washington, Washington, USA )
2 Dec 2014
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients
Prof Elizabeth Swisher - University of Washington, Washington, USA
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients ( Prof Elizabeth Swisher - University of Washington, Washington, USA )
27 Nov 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation